z-logo
open-access-imgOpen Access
Chemical Constituents from Solenostemma argel and their Cholinesterase Inhibitory Activity
Author(s) -
Rym Gouta Demmak,
Simon Bordage,
Abederrahmane Bensegueni,
Naima Boutaghane,
Thierry Hennebelle,
El Hassen Mokrani,
Sevser Şahpaz
Publication year - 2019
Publication title -
natural product sciences
Language(s) - English
Resource type - Journals
eISSN - 2288-9027
pISSN - 1226-3907
DOI - 10.20307/nps.2019.25.2.115
Subject(s) - butyrylcholinesterase , acetylcholinesterase , chemistry , cholinesterase , aché , stereochemistry , kaempferol , biochemistry , enzyme , pharmacology , flavonoid , biology , antioxidant
− Alzheimer’s disease is a chronic neurodegenerative disorder with no curative treatment. The commercially available drugs, which target acetylcholinesterase, are not satisfactory. The aim of this study was to investigate the cholinesterase inhibitory activity of Solenostemma argel aerial part. Eight compounds were isolated and identified by NMR: kaempferol-3-O-glucopyranoside (1), kaempferol (2), kaempferol-3-glucopyranosyl(1→6)rhamnopyranose (3) p-hydroxybenzoic acid (4), dehydrovomifoliol (5), 14,15-dihydroxypregn-4-ene-3,20-dione (6), 14,15-dihydroxy-pregn-4-ene-3,20-dione-15β-D-glucopyranoside (7) and solargin I (8). Two of them (compounds 2 and 3) could inhibit over 50 % of butyrylcholinesterase activity at 100 μM. Compound (2) displayed the highest inhibitory effect against acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) with a slight selectivity towards the latter. Molecular docking studies supported the in vitro results and revealed that (2) had made several hydrogen and π-π stacking interactions which could explain the compound potency to inhibit AChE and BChE.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom